Plasma Concentration of Amino-Terminal Pro-Brain Natriuretic Peptide in Chronic Heart Failure: Prediction of Cardiovascular Events and Interaction With the Effects of Rosuvastatin-Reference-Cited by-同舟云学术

Plasma Concentration of Amino-Terminal Pro-Brain Natriuretic Peptide in Chronic Heart Failure: Prediction of Cardiovascular Events and Interaction With the Effects of Rosuvastatin

Published:2009-11 Issue:20 Volume:54 Page:1850-1859
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Cleland John G.F.,McMurray John J.V.,Kjekshus John,Cornel Jan H.,Dunselman Peter,Fonseca Cândida,Hjalmarson Åke,Korewicki Jerzy,Lindberg Magnus,Ranjith Naresh,van Veldhuisen Dirk J.,Waagstein Finn,Wedel Hans,Wikstrand John

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference25 articles.

1. Changes in brain natriuretic peptide and norepinephrine over time and mortality and morbidity in the Valsartan Heart Failure Trial (Val-HeFT);Anand;Circulation,2003

2. Prognostic value of changes in N-terminal pro-brain natriuretic peptide in Val-HeFT (Valsartan Heart Failure Trial);Masson;J Am Coll Cardiol,2008

3. Prognostic impact of plasma N-terminal pro-brain natriuretic peptide in severe congestive heart failure;Hartmann;Circulation,2004

4. Predicting the long-term effects of cardiac resynchronisation therapy on mortality from baseline variables and the early response: a report from CARE-HF (Cardiac Resynchronization in Heart Failure);Cleland;J Am Coll Cardiol,2008

5. Prognostic importance of plasma NT-pro BNP in chronic heart failure in patients treated with a beta-blocker: results from the Carvedilol Or Metroprolol European Trial (COMET) trial;Olsson;Eur J Heart Fail,2007

Cited by 191 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Executive summary of the Hellenic Atherosclerosis Society guidelines for the diagnosis and treatment of dyslipidemias - 2023;Atherosclerosis Plus;2024-03

2. S₂I₂N_0–3 score predicts short‐ and long‐term mortality and morbidity in HFrEF: a post‐hoc analysis of the GUIDE‐IT trial;ESC Heart Failure;2024-02-07

3. Heart Failure Treatment in 2023: Is There a Place for Lipid Lowering Therapy?;Current Atherosclerosis Reports;2023-12

4. Preventing new-onset heart failure: Intervening at stage A;American Journal of Preventive Cardiology;2023-12

5. Statins in Patients With Established Heart Failure: Time for Reflection;Journal of Cardiovascular Pharmacology;2023-11